Treatment of hepatitis C virus with direct-acting antivirals: Practical aspects and current situation
Publication date: Available online 6 December 2017 Source:Revista Clínica Española (English Edition) Author(s): M.J. Vivancos, A. Moreno, C. Quereda Hepatitis C virus infection is a significant public health problem. The introduction of direct-acting antiviral agents, whose efficacy is greater than 90% in all patient groups (including those with cirrhosis), has represented a highly relevant change compared with classical interferon-based therapies. Tolerance for these antiviral agents is significantly better, and the treatment duration is shorter. This review updates the treatment of hepatitis C virus infection with the new direct-acting antiviral agents.
Source: Revista Clinica Espanola - Category: Internal Medicine Source Type: research
More News: Cirrhosis | Hepatitis | Hepatitis C | Internal Medicine | International Medicine & Public Health